Operating Lease, Liability, Noncurrent of Y-mAbs Therapeutics, Inc. from 31 Mar 2019 to 30 Jun 2025

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.
Summary
Y-mAbs Therapeutics, Inc. quarterly Operating Lease, Liability, Noncurrent in USD history and change rate from 31 Mar 2019 to 30 Jun 2025.
  • Y-mAbs Therapeutics, Inc. Operating Lease, Liability, Noncurrent for the quarter ending 30 Jun 2025 was $2,638,000, a 511% increase year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Liability, Noncurrent, Quarterly (USD)
Operating Lease, Liability, Noncurrent, YoY Quarterly Change (%)

Y-mAbs Therapeutics, Inc. Quarterly Operating Lease, Liability, Noncurrent (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2025 $2,638,000 +$2,206,000 +511% 30 Jun 2025 10-Q 08 Aug 2025 2025 Q2
Q1 2025 $148,000 -$145,000 -49% 31 Mar 2025 10-Q 13 May 2025 2025 Q1
Q4 2024 $190,000 -$327,000 -63% 31 Dec 2024 10-Q 08 Aug 2025 2025 Q2
Q3 2024 $299,000 -$426,000 -59% 30 Sep 2024 10-Q 08 Nov 2024 2024 Q3
Q2 2024 $432,000 +$16,000 +3.8% 30 Jun 2024 10-Q 12 Aug 2024 2024 Q2
Q1 2024 $293,000 -$336,000 -53% 31 Mar 2024 10-Q 07 May 2024 2024 Q1
Q4 2023 $517,000 -$382,000 -42% 31 Dec 2023 10-K 04 Mar 2025 2024 FY
Q3 2023 $725,000 -$294,000 -29% 30 Sep 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 $416,000 -$886,000 -68% 30 Jun 2023 10-Q 10 Aug 2023 2023 Q2
Q1 2023 $629,000 -$969,000 -61% 31 Mar 2023 10-Q 08 May 2023 2023 Q1
Q4 2022 $899,000 -$952,000 -51% 31 Dec 2022 10-K 29 Feb 2024 2023 FY
Q3 2022 $1,019,000 +$365,000 +56% 30 Sep 2022 10-Q 07 Nov 2022 2022 Q3
Q2 2022 $1,302,000 +$314,000 +32% 30 Jun 2022 10-Q 08 Aug 2022 2021 Q3
Q1 2022 $1,598,000 +$83,000 +5.5% 31 Mar 2022 10-Q 09 May 2022 2022 Q1
Q4 2021 $1,851,000 -$162,000 -8% 31 Dec 2021 10-K 30 Mar 2023 2022 FY
Q3 2021 $654,000 -$1,863,000 -74% 30 Sep 2021 10-Q 04 Nov 2021 2021 Q3
Q2 2021 $988,000 -$411,000 -29% 30 Jun 2021 10-Q 09 Aug 2021 2021 Q2
Q1 2021 $1,515,000 -$28,000 -1.8% 31 Mar 2021 10-Q 06 May 2021 2021 Q1
Q4 2020 $2,013,000 +$299,000 +17% 31 Dec 2020 10-K 01 Mar 2022 2021 FY
Q3 2020 $2,517,000 +$696,000 +38% 30 Sep 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 $1,399,000 -$581,000 -29% 30 Jun 2020 10-Q 06 Aug 2020 2020 Q2
Q1 2020 $1,543,000 -$590,000 -28% 31 Mar 2020 10-Q 07 May 2020 2020 Q1
Q4 2019 $1,714,000 31 Dec 2019 10-K 01 Mar 2021 2020 FY
Q3 2019 $1,821,000 30 Sep 2019 10-Q 13 Nov 2019 2019 Q3
Q2 2019 $1,980,000 30 Jun 2019 10-Q 14 Aug 2019 2019 Q2
Q1 2019 $2,133,000 31 Mar 2019 10-Q 10 May 2019 2019 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.